Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Neuroblastoma|Ovarian Cancer|Testicular Germ Cell Tumor
Interventions: DIETARY_SUPPLEMENT: Lactobacillus rhamnosus GG
Sponsor: Rutgers, The State University of New Jersey
Collaborators: National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey